Detalles de la búsqueda
1.
Long-term efficacy (up to 68 weeks) of Baricitinib in combination with topical corticosteroids in adult patients with moderate-to-severe atopic dermatitis: Analysis of treatment responders, partial responders and nonresponders originating from study BREEZE-AD7.
J Eur Acad Dermatol Venereol;
37(5): 1036-1045, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36514996
2.
Baricitinib in Patients with Refractory Rheumatoid Arthritis.
N Engl J Med;
374(13): 1243-52, 2016 Mar 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-27028914
3.
JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial.
Nephrol Dial Transplant;
33(11): 1950-1959, 2018 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29481660
4.
Safety Profile of Baricitinib in Patients with Active Rheumatoid Arthritis with over 2 Years Median Time in Treatment.
J Rheumatol;
46(1): 7-18, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30219772
5.
Effect on platelet reactivity from a prasugrel loading dose after a clopidogrel loading dose compared with a prasugrel loading dose alone: Transferring From Clopidogrel Loading Dose to Prasugrel Loading Dose in Acute Coronary Syndrome Patients (TRIPLET): a randomized controlled trial.
Circ Cardiovasc Interv;
6(5): 567-74, 2013 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24065443
Resultados
1 -
5
de 5
1
Próxima >
>>